Artal Group S.A. has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $129 Million distributed in 2 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Lexicon Pharmaceuticals, Inc. with a value of $129M and Cava Group Inc with a value of $0.

Examining the 13F form we can see an increase of $66.7M in the current position value, from $62.6M to 129M.

Artal Group S.A. is based out at Luxembourg, N4

Below you can find more details about Artal Group S.A. portfolio as well as his latest detailed transactions.

Portfolio value $129 Million
Healthcare: $129 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 2
  • Current Value $129 Million
  • Prior Value $62.6 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.